Letter: Helicobacter pylori and metabolic syndrome-related von Willebrand factor and plasminogen activator inhibitor-1 activity levels for outcome prediction of advanced chronic liver disease.
Jannis KountourasStergios A PolyzosEvangelos KazakosIoannis S PapanikolaouChristos LiatsosElisabeth VardakaDimitrios TzilvesEfthimia VlachakiPublished in: Alimentary pharmacology & therapeutics (2024)